Online (www.adjuvantonline.com) calculates 10-year overall survival and disease-free survival of patients with non-metastatic breast cancer, based on patient’s age, tumor size, grade, estrogen-receptor (ER) status, nodal status, and co-morbidities. This evidence concerns the gene ESR1 and neoplasm.